Get the Stockscreener App
1.80
1.12%
0.02
After Hours:
1.80
Milestone Pharmaceuticals Inc stock is traded at $1.80, with a volume of 791.20K.
It is up +1.12% in the last 24 hours and up +16.88% over the past month.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).
See More
Previous Close:
$1.78
Open:
$1.81
24h Volume:
791.20K
Relative Volume:
0.57
Market Cap:
$152.99M
Revenue:
-
Net Income/Loss:
$-59.69M
P/E Ratio:
-1.295
EPS:
-1.39
Net Cash Flow:
$-46.54M
1W Performance:
-2.17%
1M Performance:
+16.88%
6M Performance:
-9.09%
1Y Performance:
+23.29%
1-Day Range:
$1.76
$1.825
1-Week Range:
$1.75
$1.905
52-Week Range:
$0.6254
$2.75
Milestone Pharmaceuticals Inc Stock (MIST) Company Profile
Name
Milestone Pharmaceuticals Inc
Sector
Industry
Phone
(514) 336-0444
Address
1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420, MONTREAL, QC
Compare MIST with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MIST
Milestone Pharmaceuticals Inc
|
1.80 | 151.29M | 0 | -59.69M | -46.54M | -1.39 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Milestone Pharmaceuticals Inc Stock (MIST) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-05-25 | Resumed | H.C. Wainwright | Buy |
| Aug-22-24 | Initiated | Rodman & Renshaw | Buy |
| Jun-20-23 | Downgrade | Jefferies | Buy → Hold |
| Apr-22-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Mar-05-21 | Initiated | H.C. Wainwright | Buy |
| Jul-29-20 | Upgrade | Oppenheimer | Perform → Outperform |
| Jul-24-20 | Upgrade | Jefferies | Hold → Buy |
| Mar-25-20 | Downgrade | Jefferies | Buy → Hold |
| Mar-24-20 | Downgrade | Oppenheimer | Outperform → Perform |
| Mar-24-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jun-04-19 | Initiated | Oppenheimer | Outperform |
| Jun-03-19 | Initiated | Cowen | Outperform |
| Jun-03-19 | Initiated | Jefferies | Buy |
| Jun-03-19 | Initiated | Piper Jaffray | Overweight |
View All
Milestone Pharmaceuticals Inc Stock (MIST) Latest News
Will Breakout in Milestone Pharmaceuticals Inc. Sustain Through Next WeekVolume Spike & AI Powered Market Trend Analysis - beatles.ru
Can Milestone Pharmaceuticals Inc. be the next market leaderCEO Change & Real-Time Buy Signal Alerts - خودرو بانک
Is Milestone Pharmaceuticals Inc. likely to announce a buybackMarket Performance Summary & Free Safe Entry Trade Signal Reports - خودرو بانک
Has Milestone Pharmaceuticals Inc. found a price floor2025 Trading Recap & Daily Stock Trend Reports - Newser
What is Milestone Pharmaceuticals Inc. s 5 year growth outlookQuarterly Trade Summary & Growth Oriented Trade Recommendations - خودرو بانک
Short interest data insights for Milestone Pharmaceuticals IncWeekly Loss Report & Technical Analysis for Trade Confirmation - Newser
Tools to assess Milestone Pharmaceuticals Inc.’s risk profileJuly 2025 Gainers & Low Drawdown Momentum Trade Ideas - Newser
Live market analysis of Milestone Pharmaceuticals Inc.Sell Signal & Low Drawdown Trading Techniques - Newser
Layoff Tracker: AC Immune To Cut 30% of Workforce - biospace.com
Historical volatility pattern of Milestone Pharmaceuticals Inc. visualized2025 Market Outlook & Daily Technical Stock Forecast Reports - Newser
Risk vs reward if holding onto Milestone Pharmaceuticals Inc.Swing Trade & Real-Time Market Sentiment Reports - Newser
How to escape a deep drawdown in Milestone Pharmaceuticals Inc.Watch List & Real-Time Volume Trigger Notifications - Newser
Is Milestone Pharmaceuticals Inc. stock reversal real or fake2025 Analyst Calls & Free Accurate Trade Setup Notifications - Newser
Key metrics from Milestone Pharmaceuticals Inc.’s quarterly dataWeekly Stock Report & Precise Buy Zone Identification - Newser
Growth Recap: Is Milestone Pharmaceuticals Inc. stock influenced by commodity prices2025 Earnings Impact & Stepwise Trade Signal Guides - خودرو بانک
Visual trend scoring systems applied to Milestone Pharmaceuticals Inc.Portfolio Update Report & Weekly High Potential Stock Alerts - Newser
Why Milestone Pharmaceuticals Inc. is moving todayNew Guidance & Real-Time Market Trend Scan - Newser
Measuring Milestone Pharmaceuticals Inc.’s beta against major indicesForecast Cut & AI Forecast for Swing Trade Picks - Newser
What recovery options are there for Milestone Pharmaceuticals Inc.Recession Risk & Daily Profit Maximizing Tips - Newser
Visual analytics tools that track Milestone Pharmaceuticals Inc. performanceTrade Performance Summary & Community Verified Watchlist Alerts - Newser
Relative strength of Milestone Pharmaceuticals Inc. in sector analysis2025 Macro Impact & Step-by-Step Trade Execution Guides - Newser
Can technical indicators confirm Milestone Pharmaceuticals Inc.’s reversal2025 Earnings Impact & Weekly High Potential Stock Alerts - Newser
Short interest data insights for Milestone Pharmaceuticals Inc.2025 Technical Overview & Safe Entry Trade Signal Reports - Newser
Is Milestone Pharmaceuticals Inc. still worth holding after the dipJuly 2025 PostEarnings & Short-Term Swing Trade Alerts - Newser
How liquid is Milestone Pharmaceuticals Inc. stock2025 Earnings Impact & Daily Chart Pattern Signals - خودرو بانک
ANI Pharmaceuticals, Inc. (ANIP) Hits Milestone with Cortrophin Gel Prefilled Syringe Launch - Yahoo Finance
Is Milestone Pharmaceuticals Inc. a momentum stockOil Prices & Comprehensive Market Scan Insights - خودرو بانک
Can machine learning forecast Milestone Pharmaceuticals Inc. recoveryJuly 2025 Pullbacks & Low Volatility Stock Suggestions - Newser
What’s the profit margin of Milestone Pharmaceuticals Inc.July 2025 Summary & Long-Term Growth Plans - خودرو بانک
Is Milestone Pharmaceuticals Inc. stock showing strong momentum2025 Winners & Losers & Risk Adjusted Swing Trade Ideas - خودرو بانک
Milestone Pharmaceuticals Inc. stock chart pattern explained2025 Key Lessons & Capital Efficiency Focused Strategies - Newser
Why Milestone Pharmaceuticals Inc. stock attracts strong analyst attentionJuly 2025 Movers & Weekly High Return Opportunities - Newser
Sector ETF Data Correlates with Strength in Milestone Pharmaceuticals Inc.July 2025 Chart Watch & Stock Market Timing Techniques - beatles.ru
How to build a custom watchlist for Milestone Pharmaceuticals Inc.Earnings Summary Report & Community Driven Trade Alerts - Newser
Milestone Pharmaceuticals Inc. Tests 50 Day MA After Sharp Decline getLinesFromResByArray error: size == 0 - 강소기업뉴스
Is it time to cut losses on Milestone Pharmaceuticals Inc.Market Growth Review & Detailed Earnings Play Strategies - Newser
Will Milestone Pharmaceuticals Inc. price bounce be sustainable2025 Historical Comparison & Long-Term Capital Growth Strategies - Newser
Price action breakdown for Milestone Pharmaceuticals Inc.Insider Selling & Stock Portfolio Risk Management - Newser
Chart based exit strategy for Milestone Pharmaceuticals Inc.Earnings Overview Report & Growth Focused Entry Point Reports - Newser
Does Milestone Pharmaceuticals Inc. show high probability of rebound2025 Year in Review & Long-Term Capital Growth Ideas - Newser
What to expect from Milestone Pharmaceuticals Inc. in the next 30 daysJuly 2025 Patterns & Real-Time Volume Trigger Notifications - Newser
Does Milestone Pharmaceuticals Inc. fit your quant trading modelJuly 2025 Outlook & Short-Term High Return Strategies - Newser
Milestone Pharmaceuticals Inc Stock (MIST) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):